Developing innovative treatments to treat infectious disease through clinical trial
Long Covid – 19
Long-term COVID refers to the persistence of symptoms beyond the acute phase of COVID-19, often affecting multiple organ systems and requiring ongoing medical management and support.
This clinical study aims to evaluate novel antiviral therapies’ safety, efficacy, and tolerability in individuals experiencing long-term COVID-19 symptoms. By comprehensively examining these aspects, we aim to investigate how these therapies perform over time in managing persistent COVID-19 symptoms and better individuals’ wellbeing.
Eligibility Criteria
Age
18 years or older
Gender
Male & Female
Condition
Long term COVID
Location
Connecticut
Status
Recruiting
